Novel tricyclic pyrazolopyrimidines as potent and selective GPR119 agonists

被引:7
作者
Azimioara, Mihai [1 ]
Alper, Phil [1 ]
Cow, Christopher [1 ]
Mutnick, Daniel [1 ]
Nikulin, Victor [1 ]
Lelais, Gerald [1 ]
Mecom, John [1 ]
McNeill, Matthew [1 ]
Michellys, Pierre-Yves [1 ]
Wang, Zhiliang [1 ]
Reding, Esther [1 ]
Paliotti, Michael [1 ]
Li, Jing [1 ]
Bao, Dingjiu [1 ]
Zoll, Jocelyn [1 ]
Kim, Young [1 ]
Zimmerman, Matthew [1 ]
Groessl, Todd [1 ]
Tuntland, Tove [1 ]
Joseph, Sean B. [1 ]
McNamara, Peter [1 ]
Seidel, H. Martin [1 ]
Epple, Robert [1 ]
机构
[1] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA
关键词
GPCR agonists; GPR119; Tricyclic pyrazolopyrimidines; Type; 2; diabetes; PROTEIN-COUPLED RECEPTOR; DISCOVERY; SECRETION; CELLS;
D O I
10.1016/j.bmcl.2014.10.010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Systematic SAR optimization of the GPR119 agonist lead 1, derived from an internal HTS campaign, led to compound 29. Compound 29 displays significantly improved in vitro activity and oral exposure, leading to GLP1 elevation in acutely dosed mice and reduced glucose excursion in an OGTT study in rats at doses >= 10 mg/kg. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5478 / 5483
页数:6
相关论文
共 14 条
  • [1] Discovery of structurally novel, potent and orally efficacious GPR119 agonists
    Alper, Phil
    Azimioara, Mihai
    Cow, Christopher
    Mutnick, Daniel
    Nikulin, Victor
    Michellys, Pierre-Yves
    Wang, Zhiliang
    Reding, Esther
    Paliotti, Michael
    Li, Jing
    Bao, Dingjiu
    Zoll, Jocelyn
    Kim, Young
    Zimmerman, Matthew
    Groessel, Todd
    Tuntland, Tove
    Joseph, Sean B.
    McNamara, Peter
    Seidel, H. Martin
    Epple, Robert
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (10) : 2383 - 2387
  • [2] Highly Enantioselective Copper-Catalyzed Alkylation of β-Ketoesters and Subsequent Cyclization to Spirolactones/Bi-spirolactones
    Deng, Qing-Hai
    Wadepohl, Hubert
    Gade, Lutz H.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (06) : 2946 - 2949
  • [3] The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    Drucker, Daniel J.
    Nauck, Michael A.
    [J]. LANCET, 2006, 368 (9548) : 1696 - 1705
  • [4] GPR119 as a fat sensor
    Hansen, Harald S.
    Rosenkilde, Mette M.
    Holst, Jens J.
    Schwartz, Thue W.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (07) : 374 - 381
  • [5] HILLEBRAND S, 2006, Patent No. 2006005551
  • [6] Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis
    Ichimura, Atsuhiko
    Hirasawa, Akira
    Hara, Takafumi
    Tsujimoto, Gozoh
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2009, 89 (3-4) : 82 - 88
  • [7] Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
    Itoh, Y
    Kawamata, Y
    Harada, M
    Kobayashi, M
    Fujii, R
    Fukusumi, S
    Ogi, K
    Hosoya, M
    Tanaka, Y
    Uejima, H
    Tanaka, H
    Maruyama, M
    Satoh, R
    Okubo, S
    Kizawa, H
    Komatsu, H
    Matsumura, F
    Noguchi, Y
    Shinobara, T
    Hinuma, S
    Fujisawa, Y
    Fujino, M
    [J]. NATURE, 2003, 422 (6928) : 173 - 176
  • [8] Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways
    Lan, H.
    Lin, H. V.
    Wang, C. F.
    Wright, M. J.
    Xu, S.
    Kang, L.
    Juhl, K.
    Hedrick, J. A.
    Kowalski, T. J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (08) : 2799 - 2807
  • [9] The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?
    Mancini, Arturo D.
    Poitout, Vincent
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2013, 24 (08) : 398 - 407
  • [10] The therapeutic potential of GPR119 agonists for type 2 diabetes
    Ohishi, Takahide
    Yoshida, Shigeru
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (03) : 321 - 328